HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christine Bayer Selected Research

Christine Bayer Research Topics

Disease

16Neoplasms (Cancer)
08/2017 - 02/2008
14Hypoxia (Hypoxemia)
01/2017 - 05/2007
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 05/2007
6Squamous Cell Carcinoma of Head and Neck
08/2017 - 07/2007
3Neoplasm Metastasis (Metastasis)
08/2017 - 12/2014
3Head and Neck Neoplasms (Head and Neck Cancer)
08/2017 - 06/2011
3Carcinoma (Carcinomatosis)
12/2014 - 07/2007

Drug/Important Bio-Agent (IBA)

8pimonidazoleIBA
01/2017 - 03/2008
5Cisplatin (Platino)FDA LinkGeneric
08/2017 - 02/2008
5Proteins (Proteins, Gene)FDA Link
01/2016 - 05/2007
5Plasminogen Activator Inhibitor 1IBA
11/2012 - 05/2007
4fluoromisonidazoleIBA
01/2017 - 06/2011
4Plasminogen InactivatorsIBA
11/2012 - 05/2007
4bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
11/2012 - 04/2011
3Biomarkers (Surrogate Marker)IBA
08/2017 - 03/2014
3DNA (Deoxyribonucleic Acid)IBA
01/2016 - 12/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2012 - 03/2008
2Oxygen (Dioxygen)IBA
01/2017 - 05/2007
25- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
05/2015 - 01/2012
2Heat-Shock Proteins (Heat-Shock Protein)IBA
05/2015 - 01/2012
2HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
06/2014 - 03/2014
2PlasminogenIBA
03/2008 - 05/2007
1LigandsIBA
08/2017
1Chemokine ReceptorsIBA
08/2017
1Eosine Yellowish-(YS) (Eosin)IBA
01/2017
1Hematoxylin (Haematoxylon)IBA
01/2017
1Radiation-Sensitizing AgentsIBA
05/2015
1SuspensionsIBA
06/2014
1AntigensIBA
11/2012
1EnzymesIBA
11/2012
1ImmunosorbentsIBA
11/2012
1Growth Factor ReceptorsIBA
01/2012
1tanespimycin (17AAG)IBA
01/2012
1Transforming Growth Factor beta1 (TGF beta 1)IBA
02/2010
1Small Interfering RNA (siRNA)IBA
02/2010
1Pharmaceutical PreparationsIBA
02/2008
1Tirapazamine (SR 4233)IBA
02/2008
1Messenger RNA (mRNA)IBA
05/2007
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
05/2007
1Urokinase Plasminogen Activator ReceptorsIBA
05/2007

Therapy/Procedure

7Radiotherapy
06/2014 - 07/2007
4Chemoradiotherapy
08/2017 - 12/2014
3Therapeutics
01/2017 - 06/2011
1Drug Therapy (Chemotherapy)
08/2017
1Adjuvant Radiotherapy
08/2017
1Injections
02/2008